Clinical Trial Update: Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase I/II clinical trial evaluating ribavirin as monotherapy in patients with malignant solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Jewish General Hospital | Conditions: Malignant Solid Tumor | Phase 1, Phase 2 | Status: TERMINATED